Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid Tumors
Clinical trial NCT07773454 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07773454
- Sponsor
- Exelixis
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-30
- Primary completion
- 2028-07-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.